Open AccessLow-Intensity Shockwave Therapy (LI-ESWT) in Diabetic Kidney Disease: Results from an Open-Label Interventional Clinical Trial
Author(s) -
Sune Moeller Skov-Jeppesen,
Knud Bonnet Yderstræde,
Boye L. Jensen,
Claus Bistrup,
Milad Hanna,
Lars Lund
Publication year - 2021
Publication title -
international journal of nephrology and renovascular disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.846
H-Index - 27
ISSN - 1178-7058
DOI - 10.2147/ijnrd.s315143
Subject(s) - medicine , albuminuria , urology , renal function , kidney disease , vascular endothelial growth factor , excretion , vegf receptors
Treatment with low-intensity shockwave therapy (LI-ESWT) is associated with angiogenesis and is suggested as a treatment for different types of vascular diseases. It was hypothesized that LI-ESWT improves the renal filtration barrier and halts the progression of GFR decline in diabetic kidney disease (DKD) potentially through VEGF and NO formation. We present the first data on LI-ESWT in human DKD.